Mukesh K Nyati Selected Research

Mukesh K Nyati Research Topics

Disease

31	Neoplasms (Cancer) 03/2024 - 04/2002
9	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 01/2006
5	Colorectal Neoplasms (Colorectal Cancer) 02/2019 - 04/2002
4	Squamous Cell Carcinoma of Head and Neck 12/2016 - 04/2010
4	Prostatic Neoplasms (Prostate Cancer) 10/2012 - 02/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 10/2015
3	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2013
3	Carcinoma (Carcinomatosis) 01/2006 - 02/2003
2	Carcinogenesis 12/2016 - 05/2016
1	Oropharyngeal Neoplasms 01/2023
1	Rectal Neoplasms (Rectal Cancer) 02/2019
1	Radiation Pneumonitis 07/2017
1	Pneumonia (Pneumonitis) 07/2017
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 09/2013
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2011
1	Adenocarcinoma of Lung 07/2011
1	Lymphoma (Lymphomas) 04/2010
1	Neoplasm Metastasis (Metastasis) 02/2009
1	Glioblastoma (Glioblastoma Multiforme) 09/2007
1	Inborn Urea Cycle Disorders 09/2007
1	Weight Loss (Weight Reduction) 04/2007
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2006
1	Colonic Neoplasms (Colon Cancer) 02/2003

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2004
7	Proteins (Proteins, Gene)FDA Link 08/2021 - 11/2009
6	Cetuximab (Erbitux)FDA Link 01/2023 - 04/2007
6	Phosphotransferases (Kinase)IBA 08/2021 - 01/2004
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 04/2007
3	Cisplatin (Platino)FDA LinkGeneric 01/2015 - 04/2010
3	geldanamycinIBA 02/2014 - 08/2012
3	Gemcitabine FDA Link 06/2011 - 01/2006
3	EnzymesIBA 01/2010 - 04/2002
3	Fluorouracil (Carac)FDA LinkGeneric 07/2006 - 04/2002
2	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 10/2020 - 08/2012
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 09/2013
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2016 - 08/2012
2	Small Interfering RNA (siRNA)IBA 12/2016 - 07/2011
2	Peptides (Polypeptides)IBA 02/2014 - 09/2013
2	Biomarkers (Surrogate Marker)IBA 09/2013 - 02/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2011 - 10/2011
2	Messenger RNA (mRNA)IBA 07/2011 - 02/2003
2	Sarcosine (Methylglycine)IBA 09/2010 - 02/2009
2	Gefitinib (Iressa)FDA Link 04/2007 - 01/2006
2	ProdrugsIBA 02/2003 - 04/2002
2	Cytosine DeaminaseIBA 02/2003 - 04/2002
2	Flucytosine (Ancobon)FDA Link 02/2003 - 04/2002
1	LectinsIBA 03/2024
1	Antiviral Agents (Antivirals)IBA 03/2024
1	Polysaccharides (Glycans)IBA 03/2024
1	Mannose (D-Mannose)IBA 03/2024
1	RNA (Ribonucleic Acid)IBA 01/2023
1	InterferonsIBA 01/2023
1	Cell-Penetrating PeptidesIBA 08/2021
1	CrizotinibIBA 02/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017
1	thiamine triphosphorate (TTP)IBA 07/2017
1	pevonedistatIBA 05/2016
1	AntibodiesIBA 09/2015
1	Oncogene Proteins (Oncogene Protein)IBA 09/2015
1	Epidermal Growth Factor (EGF)IBA 02/2014
1	Antineoplastic Agents (Antineoplastics)IBA 02/2014
1	C-terminal binding proteinIBA 10/2012
1	Co-Repressor ProteinsIBA 10/2012
1	Monoclonal AntibodiesIBA 08/2012
1	LuciferasesIBA 10/2011
1	Bortezomib (Velcade)FDA Link 09/2011
1	Caspase 3 (Caspase-3)IBA 06/2011
1	UbiquitinIBA 04/2010
1	Ligases (Synthetase)IBA 04/2010
1	AndrogensIBA 11/2009
1	Proto-Oncogene Proteins c-etsIBA 11/2009
1	DNA (Deoxyribonucleic Acid)IBA 11/2009
1	5' Untranslated Regions (5' UTR)IBA 11/2009
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2009
1	TransferasesIBA 02/2009
1	Amino Acids FDA Link 02/2009
1	Radiation-Sensitizing AgentsIBA 09/2007
1	Histone Deacetylase InhibitorsIBA 09/2007
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2007
1	Histones (Histone)IBA 09/2007
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2007
1	Mitogen-Activated Protein Kinase 3IBA 12/2006
1	Mitogen-Activated Protein Kinase PhosphatasesIBA 12/2006
1	Propidium (Propidium Iodide)IBA 07/2006
1	tyrosine receptor (receptor, tyrosine)IBA 01/2004
1	Canertinib (CI 1033)IBA 01/2004
1	beta-Galactosidase (Lactaid)IBA 02/2003
1	Carcinoembryonic AntigenIBA 04/2002

Therapy/Procedure

11	Therapeutics 03/2024 - 04/2002
10	Radiotherapy 01/2023 - 01/2004
3	Aftercare (After-Treatment) 09/2013 - 09/2007
1	Injections 08/2021
1	Drug Therapy (Chemotherapy) 10/2015
1	Intraperitoneal Injections 02/2014
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2011
1	Combined Modality Therapy 01/2010
1	Chemoradiotherapy 04/2007